Check out our latest industry white papers. Browse now!
Sales & Support: +1 800 762 3361
Member Resources

India's leading vaccine-maker Bharat Biotech Limited is set to start human clinical trials for its COVID-19 vaccine candidate, Covaxin, which is India's first indigenously-developed vaccine against the coronavirus. Covaxin was developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV). Drug Controller General of India (DCGI) on Monday granted Bharat Biotech approval to undertake the clinical trials, which are scheduled to start across India in July.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!